NEURACAP
M&A UpdateUpdated · 7 pages · Free to read

Health Care Equipment and Supplies M&A update, 14–28 September 2026

A bi-weekly update on the Health Care Equipment and Supplies sector covering September 14–28, 2026: public market moves, company announcements, M&A reference pricing, and what the period means for operators, acquirers, and advisors.

For information only. Not an appraisal or a fairness opinion.

The deeper read: Health Care Equipment and Supplies Sector Outlook — September 2026

Key figures

Sector Median Move
-1.4%
close-to-close, 12 covered names
S&P 500 (Same Window)
+0.8%
benchmark return
AirSculpt Technologies (AIRS)
-21.0%
including -14.6% on Sep 23
Precedent Deal Multiple
13.3x
median EV/LTM EBITDA, 23 recorded deals

Read the report

NeuraCap

BI-WEEKLY INDUSTRY EVENTS & M&A UPDATE

HEALTH CARE › HEALTH CARE EQUIPMENT AND SERVICES › HEALTH CARE EQUIPMENT AND SUPPLIES

Clean Records Earn the Premium as Legal Overhang Reprices a Single Name

This update covers what moved, what companies announced, and what changed in the transaction record across September 14–28, 2026.

September 14–28, 2026

Prepared by NeuraCap AI · Confidential

Market data through 2026-09-28 · events and transactions from the two-week period 2026-09-14 → 2026-09-28

Health Care Equipment and Supplies Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice

1

1 / 7

Executive summary

Across September 14–28, 2026, the sector drifted mildly lower — 8 of 12 covered names fell with a median move of -1.4% against the S&P 500's +0.8% — while one name, AirSculpt Technologies, Inc. (AIRS), absorbed nearly all the downside at -21.0%. No new transactions closed in the window, so the trailing record of 23 precedent deals, at a 13.3x median EV/EBITDA, remains the pricing reference for buyers and sellers. The period's evidence points to an isolated repricing rather than a sector-wide re-rating.

Key findings

  • Sector drifted lower: median move -1.4% versus S&P 500 +0.8%
  • AirSculpt Technologies (AIRS) drove nearly all the downside, falling -21.0%
  • No new deals landed; precedent record still prices at 13.3x EV/EBITDA median
  • Valuation bands held: Premium 13.7x, Discount 6.6x EV/EBITDA

What each page shows

The analyst’s walkthrough of the deck, page by page.

  1. 01
    BI-WEEKLY INDUSTRY EVENTS & M&A UPDATE

    HEALTH CARE › HEALTH CARE EQUIPMENT AND SERVICES › HEALTH CARE EQUIPMENT AND SUPPLIES

    This is the cover for the Health Care Equipment and Supplies bi-weekly industry events and M&A update covering September 14–28, 2026.

    We open this bi-weekly update on Health Care Equipment and Supplies for the two weeks of September 14–28, 2026. Over the following pages we walk through what moved, what companies announced, what transacted, and what it means for operators, buyers, and advisors.

    Everything on this page

    BI-WEEKLY INDUSTRY EVENTS & M&A UPDATE HEALTH CARE › HEALTH CARE EQUIPMENT AND SERVICES › HEALTH CARE EQUIPMENT AND SUPPLIES Clean Records Earn the Premium as Legal Overhang Reprices a Single Name This update covers what moved, what companies announced, and what changed in the transaction record across September 14–28, 2026. September 14–28, 2026 Prepared by NeuraCap AI · Confidential Market data through 2026-09-28 · events and transactions from the two-week period 2026-09-14 → 2026-09-28 Health Care Equipment and Supplies Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 1

  2. 02
    THE BI-WEEKLY BOTTOM LINE

    Litigation Overhang Did the Repricing While the Rest of the Sector Drifted Lower

    This page summarizes the two-week period: a broad but mild drift lower, one name driving nearly all the downside, and an unchanged precedent pricing reference.

    Across the twelve names we cover, the median move was -1.4% against a S&P 500 return of +0.8%, so the sector drifted quietly lower while the broader market held up better. Almost all of that downside sat in a single name, and the rest of the group moved narrowly, which tells us this was a targeted repricing rather than a sector-wide re-rating. No new transactions closed in the window, so the trailing 23-deal precedent record, at a 13.3x median, is still the reference buyers argue from. That combination — an isolated stock move against an unchanged deal reference — is the headline for the period.

    Everything on this page

    THE BI-WEEKLY BOTTOM LINE Litigation Overhang Did the Repricing While the Rest of the Sector Drifted Lower The two-week period in one page · 12 covered names, close-to-close · September 14–28, 2026 Source: NeuraCap analytics platform (universe, prices, filings, transaction records); publisher-sourced news where linked; market data through 2026-09-28. Driver attributions use calibrated language and are NeuraCap reads of the recorded evidence. Health Care Equipment and Supplies Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 2 1 8 of 12 Covered Names Fell; The Median Move Was -1.4% The S&P 500 returned +0.8% over the same two-week period, so the drift across covered names was mild but broad. Four of the twelve finished higher. 2 One Name Carried Nearly All of the Downside AirSculpt Technologies, Inc. (AIRS) fell -21.0% over the window, including -14.6% on Sep 23. IRadimed Corporation (IRMD) led the upside at +5.0%. 3 The Precedent Record, Not the Period, Set the Pricing Reference No new transactions landed in the window. The trailing record of 23 precedent transactions still carries a median of 13.3x EV/EBITDA, so the reference buyers argue from is unchanged. 4 Recurring Economics Still Separate the Valuation Bands NeuraCap's standing sector lens is CY2027E EV/EBITDA at a 10.3x sector median, with the Premium band at a 13.7x median and the Discount band at 6.6x. This period gave no reason to read those bands differently. +5.0% Best mover — IRadimed Corporation (IRMD) worst: AIRS -21.0% · 4 up / 8 down of 12 covered -1.4% Sector median two-week return vs S&P 500 +0.8%

  3. 03
    PUBLIC MARKET MOVERS

    One Repricing, One Drift, and a Wide Gap Between the Two

    This page shows individual stock moves for the two-week window, highlighting the AirSculpt decline against the sector median and the S&P 500 benchmark.

    Sector names moved close-to-close with a median of -1.4%, well inside the ±5.3% materiality bar we use to flag notable moves, while the S&P 500 returned +0.8% over the same stretch. One name broke that pattern: AirSculpt Technologies, Inc. (AIRS) fell -21.0%, including a -14.6% single-day move on September 23. IRadimed Corporation (IRMD) led the upside at +5.0%. We link every move to the filings and headlines recorded in the window, and where no driver is on record, the page says so, so the read here is calibrated rather than asserted causation.

    Everything on this page

    PUBLIC MARKET MOVERS One Repricing, One Drift, and a Wide Gap Between the Two Bi-Weekly moves, close-to-close · September 14–28, 2026 · sector median -1.4% · S&P 500 +0.8% · materiality bar ±5.3% (sector-relative) Source: NeuraCap analytics platform (universe, prices, filings, transaction records); publisher-sourced news where linked; market data through 2026-09-28. Attribution links each move only to filings and headlines recorded in the window; where no driver is recorded, the page says so. Calibrated language throughout — NeuraCap reads, not asserted causation. Health Care Equipment and Supplies Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 3 Bi-Weekly return per company · teal above zero, amber below · sector median -1.4% AirSculpt Technologies, Inc. (AIRS) -21.0% Shares moved following the investor-alert notices published Sep 15 and Sep 17 announcing law-firm investigations of claims on behalf of AirSculpt investors; the available evidence suggests that overhang was the most likely driver. Legal overhang gets priced quickly where revenue depends on elective, self-pay procedure volume. COMPANY-SPECIFIC IRadimed Corporation (IRMD) +5.0% No notable in-window news was identified that clearly explains the move. The +5.0% gain sits well above the median move of -1.4%. In smaller device names, a single fund flow can outrun the median; breadth reads better than any one print. UNEXPLAINED

  4. 04
    MAJOR NEWS & INDUSTRY CATALYSTS

    What Companies Actually Announced: A Leadership Build and a Widening Legal Overhang

    This page lists the two-week period's highest-impact company announcements, each linked to its source filing or article.

    The period's news flow centered on two threads: a leadership build at one company and a widening legal overhang at another. Every 'why it matters' line here is our read of the recorded evidence, and every event links back to its source. We source in a fixed reliability order — SEC filings first, then press releases, then established outlets — and we do not draw on video or social platforms. That discipline is what lets us separate confirmed catalysts from noise.

    Everything on this page

    MAJOR NEWS & INDUSTRY CATALYSTS What Companies Actually Announced: A Leadership Build and a Widening Legal Overhang The two-week period's highest-impact events · titles link to the underlying filing or article · September 14–28, 2026 Source: NeuraCap analytics platform (universe, prices, filings, transaction records); publisher-sourced news where linked; market data through 2026-09-28. "Why it matters" lines are NeuraCap reads; each event links to its source. Sources are admitted in a fixed reliability order (SEC filings, press releases, established outlets); video and social platforms are never used. Health Care Equipment and Supplies Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 4 Sep 18 · NEWS · Business Wire A conference-participation notice carried under the SGC symbol came from a mining issuer The item is not a Superior Group of Companies, Inc. (SGC) development. NeuraCap flags it so readers do not treat a symbol collision as a sector event. Symbol-tagged newsfeeds can mix issuers; check the source before treating an item as sector signal. Sep 17 · NEWS · GlobeNewsWire Superior Group of Companies strengthened the leadership team of its outsourced services segment The appointments show where management capacity is being placed to support the segment's next phase of growth. Service and support operations are run by people; senior hires there are a signal about where growth is expected. Sep 15 · NEWS · Business Wire An acquisition-closing notice carried under the SGC symbol also came from a mining issuer Again this is not a Superior Group of Companies, Inc. (SGC) transaction, and it does not belong in the sector's deal record. NeuraCap excludes it from the period's transaction count. A clean deal record starts with confirming the party behind the ticker. Sep 24 · NEWS · PRNewsWire AirSculpt investigation notices continued into the final week of the window The notices ran repeatedly from Sep 15 through Sep 24, so the matter stayed live for the whole period rather than clearing in a day. A matter that keeps reappearing changes the timetable of any process built around it. Sep 22 · NEWS · GlobeNewsWire Further investor-alert notices on AirSculpt kept the litigation matter in front of the market Repetition of the same notice through the window kept attention on the company's disclosure record rather than on its procedure volume or utilisation. That shift in attention is itself the sector theme this period. When attention moves from operating metrics to legal process, the operating story gets heard later. Sep 19 · NEWS · Business Wire A second law firm opened an investigation into claims on behalf of AirSculpt investors A second firm joining the matter broadens the overhang rather than settling it. For a business built on elective procedure volume, unresolved legal matters weigh on how buyers and boards read earnings quality. Open legal matters sit alongside quality and reimbursement findings as items a buyer will price or escrow.

  5. 05
    M&A & STRATEGIC ACTIVITY

    Reference Multiples Do the Work When No New Transactions Land

    This page shows that no new transactions closed in the window, so the reference pricing comes from the trailing set of 23 precedent deals at a 13.3x median.

    No new deals were announced in this window, so the trailing precedent record does the work: 23 recorded transactions at a median of 13.3x EV/LTM EBITDA. We take deal multiples as LTM at announcement where disclosed, and we read the strategic rationale behind each deal rather than assert it as fact. Because the reference set didn't move, buyers and sellers are still pricing off the same 13.3x anchor they had two weeks ago. That stability is itself useful information for anyone benchmarking a live process.

    Everything on this page

    M&A & STRATEGIC ACTIVITY Reference Multiples Do the Work When No New Transactions Land September 14–28, 2026 · precedent transactions: 23 recorded deals · median 13.3x EV/LTM EBITDA Source: NeuraCap analytics platform (universe, prices, filings, transaction records); publisher-sourced news where linked; market data through 2026-09-28. Deal multiples are LTM at announcement where disclosed; "why the deal happened" is a NeuraCap read of the recorded evidence. No old transactions are re-presented as news. Health Care Equipment and Supplies Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 5 No Material Transactions Announced No material sector transactions were announced during the period. The trailing record of 23 precedent transactions, at a median of 13.3x EV/EBITDA, remains the reference both sides will argue from. A quiet two-week period is information: buyer appetite, financing conditions and seller expectations all read through a period with no new deals. The precedent transactions alongside still frame what buyers have paid. 23 Recorded precedent transactions the reference set buyers and sellers price against 13.3x Precedent median EV/LTM EBITDA LTM at announcement, where disclosed

  6. 06
    WHAT IT MEANS

    What the Period Means for Operators, Buyers and Advisors

    This page translates the period's findings into implications for operators, acquirers, and advisors.

    For owners and operators, the steadier names in the group were carried by familiar recurring economics — consumable pull-through, service contract attach, and procedure volume per instrument. For acquirers, the leverage this period sits in diligence, not in the reference set, since the comparison anchor stays fixed on the 23-deal, 13.3x median. For advisors, the story to tell clients is separation: eight of twelve covered names fell with a median move of -1.4%, while one name moved -21.0% on a matter distinct from sector operating performance. These are observations for planning purposes, not recommendations.

    Everything on this page

    WHAT IT MEANS What the Period Means for Operators, Buyers and Advisors The two-week period translated for the people who act on it · NeuraCap view · observations, not recommendations Source: NeuraCap analytics platform (universe, prices, filings, transaction records); publisher-sourced news where linked; market data through 2026-09-28. This page is analytical interpretation drawn from the two-week period's recorded evidence. It is not investment advice. Health Care Equipment and Supplies Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 6 Sector study 2026-09-28 EV / EBITDA (CY2027E) median 10.3x 10 companies in the study 3 valuation tiers Standing thesis: Health Care Equipment and Supplies Span Device Platforms, Hospital Consumables and Adjacent Models FOR OWNERS & OPERATORS Recurring Economics Are What Carried the Steadier Names Companies in the space traded in a narrow band, and the metrics behind that steadiness are the familiar ones: consumable pull-through per placed unit, service contract attach and renewal, recurring revenue mix, and procedure volume per instrument. FOR ACQUIRERS The Reference Set Is Unchanged, so the Leverage Sits in Diligence With no new transactions in the window, the comparison set stays anchored on 23 precedent transactions at a median of 13.3x EV/EBITDA. FOR ADVISORS Lead with Earnings Quality, Not with the Period's Noise The story to tell is separation: 8 of 12 covered names fell with a median move of -1.4%, while one name moved -21.0% on a matter unrelated to operating performance elsewhere in the sector.

  7. 07
    SOURCES & METHODOLOGY

    Sources, Methodology and Important Notice

    This page explains the sources and methodology behind the update and states the important notice governing its use.

    Every figure in this update links back to the record it was taken from — SEC filings, consensus estimates, and market prices — so nothing here rests on an unverified number. We built this two-week window through September 28, 2026, and we hold driver attributions to calibrated, evidence-based language throughout. This page is the reference for how each statement in the deck should be read.

    Everything on this page

    SOURCES & METHODOLOGY Sources, Methodology and Important Notice How this bi-weekly update is built and what each kind of statement rests on · September 14–28, 2026 · market data through 2026-09-28 Every figure in this update links to the record it was taken from; the publishers and filings drawn on for the period are listed above. Health Care Equipment and Supplies Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice 7 OBSERVED DATA Bi-Weekly stock moves are computed close-to-close over the stated window from the platform’s price series. Deal records, values and multiples come from the platform’s transaction record (SEC 8-K extractions) exactly as recorded; each figure links to its citation. Treasury rates come from the platform’s Treasury series and are shown only when the 10-year moved at least ten basis points over the window (it did not in this window, so no rate figures appear). UNIVERSE QUALITY The update universe is the platform’s approved company set for this sector, subject to a $100M market-cap floor so small, loosely related names cannot dominate the statistics. 3 names below the floor were excluded from movers and statistics for this window. EVENTS & NEWS Company events are in-window 8-K filings; news items are publisher-sourced headlines fetched for the window (and any externally supplied items, marked as such). Operational and strategic developments (deals, partnerships, launches, expansion, guidance, leadership, regulatory outcomes) are shown first; capital-return mechanics and conference appearances are limited to one each. Every event links to its source. The deck never asserts an event that has no linked record. SOURCE HIERARCHY News is admitted in a fixed order of reliability: SEC filings first, then company press releases and investor-relations communications, then transaction documents, then established outlets (Reuters, CNBC, The Wall Street Journal, Barron’s and peers). Video and social platforms — including YouTube — are never used as sources. DRIVER ATTRIBUTION A stock move is linked to an event only when the event falls inside the window, and only in calibrated language ("the move appears to reflect…", "shares moved following…"). Where no driver is recorded, the page says so and compares the move to the sector median instead. ANALYTICAL INTERPRETATION "Why it matters", "why the deal happened" and the what-it-means page are NeuraCap analytical views drawn from the recorded evidence, and are labeled as such. INHERITED CONTEXT The standing sector view (thesis, valuation lens, sector median and tiering) is inherited from the NeuraCap sector study run_20260929T153729Z_519_prod (market data as of 2026-09-28) — distilled, never re-derived. That report’s own sources page governs its content; this update reads the period against it. IMPORTANT NOTICE This report is informational only. It is not investment advice, not a recommendation to buy or sell any security, and not an offer of any kind. Readers should perform their own diligence before acting on anything described here. Linked sources this two-week period: businesswire.com · globenewswire.com · prnewswire.com

Sources and methodology

This update covers Health Care Equipment and Supplies over the 14-day window September 14–28, 2026; market data runs through September 28, 2026. The universe is the 12 listed companies whose core business is Health Care Equipment and Supplies under NeuraCap's industry classification, subject to a $100M market-capitalisation floor so that very small, loosely related names cannot dominate the movers and statistics. Companies covered: AdaptHealth Corp. (AHCO), AirSculpt Technologies, Inc. (AIRS), American Well Corporation (AMWL), Baxter International Inc. (BAX), Cerus Corporation (CERS), Inogen, Inc. (INGN), IRadimed Corporation (IRMD), LivaNova PLC (LIVN), Superior Group of Companies, Inc. (SGC), Solventum Corporation (SOLV), STERIS plc (STE), Stevanato Group S.p.A. (STVN). 3 names below the floor were excluded from the statistics: KEQU, NYXH, SRTS.

Window and company universe

This update covers Health Care Equipment and Supplies over the 14-day window September 14–28, 2026; market data runs through September 28, 2026. The universe is the 12 listed companies whose core business is Health Care Equipment and Supplies under NeuraCap's industry classification, subject to a $100M market-capitalisation floor so that very small, loosely related names cannot dominate the movers and statistics. Companies covered: AdaptHealth Corp. (AHCO), AirSculpt Technologies, Inc. (AIRS), American Well Corporation (AMWL), Baxter International Inc. (BAX), Cerus Corporation (CERS), Inogen, Inc. (INGN), IRadimed Corporation (IRMD), LivaNova PLC (LIVN), Superior Group of Companies, Inc. (SGC), Solventum Corporation (SOLV), STERIS plc (STE), Stevanato Group S.p.A. (STVN). 3 names below the floor were excluded from the statistics: KEQU, NYXH, SRTS.

How the moves and statistics are computed

Each company's period move is the change in closing price from the last close before the window to the last close inside it (close-to-close). The sector median is the median of those moves across the covered names; the index return is computed the same way for the S&P 500 over the same dates. The largest single-day move inside the window is shown for each mover. Movers are the largest gainers and losers by period move; the attribution cards prefer movers whose in-window record explains the move. Movers carry the valuation tier assigned in the standing sector study (the latest NeuraCap sector outlook) where that study rated them.

Events, news and how a move is attributed

Company events are the 8-K filings made inside the window; news items are publisher-sourced headlines for the window, admitted in a fixed order of reliability: SEC filings first, then company press releases and investor-relations communications, then established outlets (Reuters, CNBC, The Wall Street Journal, Barron's and peers). Video and social platforms are never used. A move is linked to an event only when the event falls inside the window and only in calibrated language; where nothing in the record explains a move, the update says so rather than speculating. Every event links to its source.

Transactions in the window and the trailing record

Transactions are taken from SEC filings by announcement date; 0 were announced inside the window. The trailing record of 23 recorded transactions provides the reference multiples (EV over last-twelve-month revenue or EBITDA at announcement, as disclosed). A value whose own citation describes something other than the price paid is not shown as the deal value; transactions where the acquirer and the target are the same entity are treated as reorganisations and excluded.

Sources

Prices and index levels are market data through September 28, 2026; filings are the companies' SEC filings on EDGAR; press releases are the companies' own; other news items are from the established outlets named on each card; Treasury yields are published by the U.S. Department of the Treasury. Every figure and every event in the update links to its record.

Interpretation and important notice

'Why it matters', 'why the deal happened' and the what-it-means page are NeuraCap analytical views drawn from the recorded evidence, labelled as such. The update is informational: it is not investment advice, not a recommendation to buy or sell any security and not an offer of any kind.

This report is published for information only. It is not a recommendation to buy or sell any security, an offer or solicitation, an appraisal or a fairness opinion, and no fiduciary relationship is created by reading it. Multiples that fail NeuraCap’s plausibility gates are excluded and never plotted. See the full methodology and the disclaimer.

Want this analysis for a company in Health Care Equipment and Supplies?

Company valuation reports run the same method against a single business — public or private.